10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,703,955 | -28.5% | 41,308 | -3.2% | 0.00% | -33.3% |
| Q2 2023 | $2,382,302 | +24.0% | 42,663 | +23.9% | 0.00% | +50.0% |
| Q1 2023 | $1,920,738 | +48.8% | 34,428 | -2.8% | 0.00% | 0.0% |
| Q4 2022 | $1,290,450 | +28.0% | 35,413 | +0.0% | 0.00% | +100.0% |
| Q3 2022 | $1,008,477 | -37.7% | 35,410 | -1.1% | 0.00% | -75.0% |
| Q2 2022 | $1,620,000 | -48.2% | 35,804 | -12.9% | 0.00% | -33.3% |
| Q1 2022 | $3,126,000 | -53.8% | 41,102 | -9.6% | 0.01% | -53.8% |
| Q4 2021 | $6,773,000 | +63.8% | 45,472 | +60.1% | 0.01% | +62.5% |
| Q3 2021 | $4,136,000 | -76.2% | 28,410 | -67.9% | 0.01% | -76.5% |
| Q2 2021 | $17,351,000 | +18.8% | 88,608 | +9.8% | 0.03% | +17.2% |
| Q1 2021 | $14,608,000 | +362.7% | 80,704 | +262.0% | 0.03% | +383.3% |
| Q4 2020 | $3,157,000 | +18.9% | 22,292 | +4.7% | 0.01% | 0.0% |
| Q3 2020 | $2,656,000 | +41.7% | 21,301 | +1.5% | 0.01% | +50.0% |
| Q2 2020 | $1,875,000 | – | 20,993 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |